QTREX Quantum (QTEX) Stock Analysis

What QTREX Quantum does

QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.

Key metrics

ETFs linked to QTEX

Broad-market and Technology sector ETFs an investor holding QTREX Quantum is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how QTEX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for QTREX Quantum?

QTREX Quantum trades under the ticker QTEX on NASDAQ.

Which exchange is QTEX listed on?

QTEX is listed on NASDAQ.

What sector does QTREX Quantum operate in?

QTREX Quantum is classified in the Technology sector (Computer Hardware industry).

How can PortView help analyze QTEX in a portfolio?

PortView shows QTEX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.